Insider Transactions in Q4 2022 at Cardiff Oncology, Inc. (CRDF)
Insider Transaction List (Q4 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 25
2022
|
Mark Erlander Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+29.0%
|
$10,000
$1.43 P/Share
|